Interstitial pneumonia associated with neoadjuvant chemotherapy in breast cancer

  • Authors:
    • Hidemi Kawajiri
    • Tsutomu Takashima
    • Naoyoshi Onoda
    • Shinichiro Kashiwagi
    • Tetsurou Ishikawa
    • Kosei Hirakawa
  • View Affiliations

  • Published online on: March 5, 2013     https://doi.org/10.3892/mco.2013.87
  • Pages: 433-436
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Interstitial pneumonia (IP) is a critical adverse event that may occur during anticancer chemotherapy. Physicians should be aware of the possibility of IP, particularly when dealing with patients on neoadjuvant chemotherapy (NAC) since delays in diagnosis and treatment interfere with the scheduled operation. In our institution, fluorouracil, epirubicin and cyclophosphamide (FEC) followed by weekly paclitaxel is the standard NAC regimen for operable breast cancer cases. In the present study, 95 patients with breast cancer were treated with this regimen, 5 of whom (5.3%) developed IP during NAC. All 5 cases were diagnosed when anticancer therapy was withdrawn and steroid pulse therapy was initiated. Consequently, the standard operation was immediately performed. In conclusion, physicians should be aware that IP may occur at any point during NAC and that it should be immediately diagnosed and treated to avoid delay of the therapeutic plan.
View Figures
View References

Related Articles

Journal Cover

May-June 2013
Volume 1 Issue 3

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kawajiri H, Takashima T, Onoda N, Kashiwagi S, Ishikawa T and Hirakawa K: Interstitial pneumonia associated with neoadjuvant chemotherapy in breast cancer. Mol Clin Oncol 1: 433-436, 2013
APA
Kawajiri, H., Takashima, T., Onoda, N., Kashiwagi, S., Ishikawa, T., & Hirakawa, K. (2013). Interstitial pneumonia associated with neoadjuvant chemotherapy in breast cancer. Molecular and Clinical Oncology, 1, 433-436. https://doi.org/10.3892/mco.2013.87
MLA
Kawajiri, H., Takashima, T., Onoda, N., Kashiwagi, S., Ishikawa, T., Hirakawa, K."Interstitial pneumonia associated with neoadjuvant chemotherapy in breast cancer". Molecular and Clinical Oncology 1.3 (2013): 433-436.
Chicago
Kawajiri, H., Takashima, T., Onoda, N., Kashiwagi, S., Ishikawa, T., Hirakawa, K."Interstitial pneumonia associated with neoadjuvant chemotherapy in breast cancer". Molecular and Clinical Oncology 1, no. 3 (2013): 433-436. https://doi.org/10.3892/mco.2013.87